Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

Sargent, Daniel J

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 2005 - 8664-70 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural

0732-183X

10.1200/JCO.2005.01.6071 doi


Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Chemotherapy, Adjuvant
Colonic Neoplasms--drug therapy
Combined Modality Therapy
Disease-Free Survival
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Randomized Controlled Trials as Topic
Regression Analysis
Treatment Outcome